1. 1 Bishop. M P. Mason L. B and Gallant D. M Blood pressure abnormalities in schizophrenic patients Some considerations relevant to the clinical testing of investigational drugs Curr Ther Res W (1968) 315-322.
2. 2. Ebert. M H . and Shader R I Cardiovascular effects. In Shader. R. I. and DiMascio A. (eds) Psychotropic Drug Side Effects Baltimore. The Williams & Wilkms Company. 1970 pp 149-163
3. 3 Ballon J Skin pigmentation and the phenothiazines Electrocardiographic aspects In Lehmann H E and Ban T A (eds.) Toxicity and Adverse Reaction Studies With Neuroleptics and Antidepressants Verdun: Quebec Psychopharmacological Research Association. 1967. pp 63-65
4. 4 Ballon J Electrocardiographic changes with psychoactive drugs The cardiologist s viewpoint In Lehmann and Ban Op cit.. pp 158-164
5. 5 Busfield. B L Schneller P and Capra D Depressive symptom or side effecf7 A comparative study of symptoms during pretreatment and treatment periods of patients on three antidepressant medications. J. Nerv Ment Dis 134 (1962). 339-345